(ZH) Hedge Funds Covered The Most S&P Shorts Since The Election, Sold Most USDJP

Hedge Funds Covered The Most S&P Shorts Since The Election, Sold Most USDJPY In Three Years

Looking at the most recent CFTC Commitment of Traders report, BofA makes two notable observations ahead of what may be a volatile week between the Fed's 25bps rate hike announcement on Wednesday, just hours after the Dutch General Election, and on the same day as the US debt ceiling expiration hits.
The first is that HFs short covered the most S&P 500 futures contracts in a week since the US election. Specifically, asset managers increased S&P 500 longs by $1.2bn to $78.7bn; bringing the net position to the highest since August 2015. Meanwhile, Leveraged Funds, i.e. hedge funds, decreased short by $10.2bn to -$16.4bn; net position the least short since December 2014.
Additionally, institutions bought $1.2bn S&P 500 and $0.2bn EM futures last week, but sold other equity indices: -$1.1bn NASDAQ 100, -$0.7bn Russell 2000 and -$0.4bn EAFE. HFs bought $10.2bn S&P 500, but sold other equity indices: -$0.9bn NASDAQ 100, -$0.7bn each of Russell 2000 and EM.
Also of note, as we reported yesterday, despite the exuberant money flow (and short covering) from the FOMO-followers into the broader S&P, not everyone's buying it as speculators have entirely erased their massive record net long position in the small-cap Russell 2000 index, swinging the net position to its first net short since the election.

Chemise Mercer // Flanelle Ebène - Ecru
62,50 € - La particularité de notre chemise Mercer est d'avoir son col tenu en place par deux discrets boutons cachés. La flanelle - un tissu légèrement gratté pour lui donner un toucher duveteux e...
Ad by balibaris.com
* * *
The second notable observation in last week's CFTC report according to BofA's Jue Xiong, is that institutions sold the most JPYUSD futures since February 2013. Asset Managers increased their JPY short by -$1.7bn to -$4.8bn; net position near 3-year low (4.4%tile), while leveraged funds increased short by -$0.4bn to -$2.9bn.
* * *
Finally, BofA notes that in light of the recent move wider in credit spreads, Hedge Funds may "get hurt" as they are increasing negatively correlated to the bond risk premium. Short Bias and Managed Futures are the only two strategies that provide positive correlation, i.e. benefit from higher credit spread. Macro strategy also offers better diversification in this aspect. The one-year correlation between diversified HF performance and S&P 500 price return has declined from the three-year and five-year relationship, suggesting that HFs are less relying on market exposure.
The details:


The one-year correlation between diversified HF performance and S&P 500 price return has declined from the three-year and five-year relationship, suggesting that HFs are less relying on market exposure. However, the correlation with S&P 500 varies substantially among different HF strategies. Short Bias is the only strategy that offers negative correlation or most diversification effects. Macro and Managed Futures also have lower correlation with the equity market. It is worth to point out that performance of the Merger Arbitrage strategy seems increasingly correlation to the S&P 500.
Diversified HF performance are increasing negatively correlated to the credit spread or bond risk premium. In other words, when credit spread increase, performance of HFs is expected to deteriorate. Short Bias and Managed Futures are the only two strategies that provide positive correlation, i.e. benefit from higher credit spread. While macro strategy also offers better diversification in this aspect. However, most other strategies are positioning for even lower credit spread.
Keep an eye on bond yields and spreads, especially with the 10Y blowing, but not fully crossing, the recent post-election highs.

(ZH) The 3 Biggest Picture 'Long-Short' Trades In The World

The 3 Biggest Picture 'Long-Short' Trades In The World

8 years after the beginning of "Bull & Fed's Excellent Adventure", BofA's Michael Hartnett is starting to have his doubts.
The bull market catalyst - extraordinary, unprecedented central bank policies - is fading globally and the so-called "Humpty-Dumpty' Trade looms:
The Fed has hiked 2 times in past 10 years; March 15th will be the 2nd hike in 3 months and they will continue tightening until “event”
This is the "great fall" in risk assets catalyst = hawkish Fed & weaker EPS in H2 - BofAML suggests buy long-dated SPX puts (June FOMC/ECB = volatility); accumulate gold; avoid “ZIRP winners”…CRE, HY, EM debt, NZ$

Blouson Wild // Tabac
255 € - Le blouson d'aviateur est une pièce iconique du vestiaire masculin depuis qu'il a équipé les pilotes du milieu du siècle dernier. Les bords côtes garantissent qu'aucun coup de vent ne s'eng...
Ad by balibaris.com
But Hartnett suggests there are still opportunities among the "Biggest Picture" trades...
1. Long Robots, Short Humans
"You can’t build a wall to keep the robots out"
  • Number of global robots by 2020 = 2.5 million; in 2010 was 1 million
  • Until we “tax the robots” (which we are likely to end up doing) Disruption, Demographics, Debt likely caps rise in inflation & interest rates
  • The “deflationary D’s” won’t prevent cyclical rise in inflation; but are likely to prevent a secular rise in inflation
2. Long Main Street, Short Wall Street
Economic Nationalism is back
  • Electorates are voting for trade & immigration policies to boost wages on Main Street, not for central banks to support stock & bond prices on Wall Street

3. Long Global, Short US Stocks
A multipolar world looms
  • US equities @ all-time highs; global equities 27% below all-time peak in 2007
  • US equities trade on 3.0X book; non-US equities trade on 1.3X book
  • Japan & Europe to outperform US stocks

>>> China Commerce Min Zhong Shan: Trade war between China and US would harm bot

China Commerce Min Zhong Shan: Trade war between China and US would harm both economies - press 
- Says: “Many American and western friends think that China can’t live without the US, and they’re half right... Similarly, the U.S. also can’t live without China.. Our common mission is to enhance cooperation, manage differences and achieve healthy, stable and sustainable development of our bilateral economic and trade ties."
- Looking fwd to meeting US Commerce Sec Ross; States: “I noticed that Mr. Ross used to be an excellent entrepreneur, a good negotiator and, I can say, he’s very excellent... I’m willing to deal with excellent people, because excellent people are good at thinking strategically for the long term.”

>>> What to look at this Week End - 11th & 12th of March 2017

Weekly Performance
Dow -0.49% S&P -0.44% Nasdaq -0.15% Russell -2.07% Mexico -0.66% Brazil -3.16% Nikkei +0.70% Hang Seng +0.07% CSI +0.00% Shanghai -0.17% EuroStoxx +0.38% FTSE -0.42% CAC -0.04% Dax -0.53% Ibex +2.12% MIB -0.03% SMI +0.0%
The stock market advance saw a respite this week as legislators in Washington began what is going to be the arduous process of passing healthcare reform. Rising bond yields caught investors' attention testing some key levels. The February jobs data remained robust, surpassing expectations on the payrolls, while suggesting the tightening labor market is starting to translate into upward pressure on wages. The ECB signaled that it is no longer worried about deflation and raised both its inflation and GDP forecasts for this year and next. A growing number of market participants were emboldened in their calls that central banks are falling behind the curve on removing accommodation. By Friday, futures markets were pricing in at least three hikes from the Fed this year, and some analyst were pulling forward their timetable for beginning to shrink the Fed's balance sheet. WTI crude prices careened back through the $50 mark after US crude stockpiles showed another outsized jump. Many pointed to technical/seasonal selling pressures, but nonetheless a 9% weekly decline weighed on stock sentiment. Gold prices fell back below the 200-day moving average to test $1200. For the week, the DJIA fell 0.5%, the S&P500 dropped 0.4%, and the Nasdaq lost 0.2%. 
Bonds continued to decline throughout the week, he 10-year went from 2.49% on Monday to reach a week-high 2.61%. Bonds rallied slightly after NFP. The German 10-year yield rose 7bps, reaching 0.495%, before prices recovered some ground on Friday. 

Macro :
- Fosun Wants to Invest More in Pharmaceutical Sector: Expresso
- Hedge Funds Bet Against Small Caps for 1st Time Since Nov.: CFTC
- Iran Oil Minister Says OPEC Happy With $55-$60/Bbl Crude: Etemad
- May to Ask EU to Return GBP9b When Article 50 Triggered: S.Times
- Schwarzman Sees Donald Trump Dialing Back Criticisms of China

Keep an eye on :
- ABI BB : AB InBev Chief Integration Officer Almeida Buys $10.1m of ADRs
- AIR FP : Airbus CEO Tom Enders Has a Flight Plan for Growth - Barron's
- AIG US : Berkshire Hathaway Should Consider Buying AIG: KBW
- AIRBNB IPO : Airbnb Said to Be Seeking to Hire Senior Executive: Information
- AKZA NA : Akzo Nobel Mobilizes Politicians to Prevent PPG Takeover: FD
- BAYN GY : Bayer CEO Sees EU6b Sales From 6 Pipeline Drugs: Welt am Sonntag
- BITCOIN : U.S. Rejects Application for Winklevoss Bitcoin ETF
- BMW GY : Nissan, Ford, BMW Sue Takata Over Faulty Airbag Losses
- BP/ LN : Exxon-BP Acquisition Talk Resurfaces: Is a Deal Really Likely?
- BT/A LN : BT May Face Price Controls on Broadband Services: Telegraph
- BVS LN : Bovis Homes rejects GBP 3bn bid approach from Redrow
- BVS LN : Bovis Homes Says in Talks With Galliford Try on Possible Merger
- CVRS US : Corindus Rises Post-Mkt as Philips Reports 15.5% Stake in 13D
- DENERG DC : Dong Energy to Join S&P Europe 350, Euro Plus Indexes
- DBK GY : Investigate Deutsche Bank’s Russian Ties: House Fin Cmte Dems
- DWNI GY : Vonovia CFO Kirsten Sees No New Merger With Deutsche Wohnen: BZ
- GE US : General Electric Jumps Amid Speculation About Activism
- GOOGL US : MapR Said to Hire Goldman Sachs as Lead Adviser for IPO
- HSBA LN : HSBC Said to Approach Mark Tucker for Chairman Role, Sky Reports
- ITX GY : Inditex May Raise Dividend Next Week, E.ON May Cut, BDVD Says
- ITV LN : BT may be interested in takeover of ITV following resolution of Openreach regulatory review - The Times
- JCI US : Johnson Controls Said to Explore Sale of Scott Safety: Reuters
- OR FP : The Body Shop attracts interest from CVC; former L’Occitane managing director Jacques Osti working with CVC
- LRD LN :Laird Jumps; Berenberg Says Reshaping May Spark M&A Interest
- MKS LN : M&S Considering Whitbread’s Baker for Chairman: Sunday Times
- NESN VX : Nestle’s Martello Says Yinlu Turnaround ‘Will Take Time’: SaW
- NCLH US : Norwegian Cruise Line Stock Could Rise 20% - Barron's
- UG FP : Peugeot Turned to M&A to Drive Earnings Growth - Barron's
- PHIA NA : Corindus Rises Post-Mkt as Philips Reports 15.5% Stake in 13D
- PAH3 GY : Porsche-Owning Families Want Piech Off Supervisory Board: BamS
- RL US : Ralph Lauren Holder Southeastern Reports 0.04% Stake
- RNO FP : Nissan, Ford, BMW Sue Takata Over Faulty Airbag Losses
- RSDA NA : Shell Drops Plans for Prince Rupert LNG Project in Canada
- RWE GY : RWE CEO Schmitz to Become Personnel Director: Rheinische Post
- SAN FP : Eczema drug from Regeneron tipped for blockbuster status
- SNAP US : Snap Put Volume Accelerates, Reverses Earlier Gains
- SPKE US : Spark Energy Sale Said to Be at Early Stage, DealReporter Says
- TEF SM : Telefonica Weighs Possible Deal W/ Liberty in U.K.: Expansion
- TSLA US : Elon Musk’s Offer ‘Game Changer’ for South Australia: Greens
- THYAO TI : Turkish Air ’16 Loss 47m Liras Vs 2.99b Liras Profit Yr Ago
- UBSG VX : UBS May Move More Jobs From Zurich to Regional Offices: NZZ
- VIRP FP : Virbac to Cut Debt in 2017, Could Consider M&A From 2018: Maree
- VOD LN : Vodafone Near Merger of Indian Unit With Rival Idea: Telegraph
- VOLVB SS : Cevian Capital Raises Volvo Stake by Buying 1m A-Shares: DI
- VOW3 GY : Volkswagen Brands More Autonomous Today, CEO Tells SonntagsBlick
- VNA GY : Vonovia CFO Kirsten Sees No New Merger With Deutsche Wohnen: BZ

>>> Barron's Week-End Summary

Barron's weekend summary: positive on BX, NCLH, BLL 
* Cover story: Four exchange traded fund experts-Joel Dickson of Vanguard Group, Mark Wiedman of BLK, Jim Ross of STT and Tony Rochte of Fidelity-discuss the ETF industry and topics such as the active-versus-passive debate. 
* Features: 1) Positive on BX: The alternative-asset manager has been making far more money than rivals, and its shares could see a 40% rise based on more fund raising and an increase in distributable earnings; 2) Positive on NCLH: Shares may have trailed those of other cruise line companies during the past year, but stronger booking trends and higher-paying passengers could send them up by 20%; 3) Positive on BLL: Shares of the world's largest beverage-can maker have dropped amid concerns about its Rexam acquisition, presenting an opportunity for investors to buy in on the cheap;
* Tech Trader: Asking whether SNAP is more like FB or TWTR is the wrong question-the recently listed company's identity crisis is more reminiscent of onetime highflyer GPRO, a camera company that sought to be a media company, much like Snap wants to be. 
* Trader: "A sense of unease hangs over the market, especially after the price of oil fell 9.1% last week, sinking to its lowest level since November. And the market is certainly overdue for a selloff"; "Right now, confidence is surging in the market, but it has yet to translate into tangible gains"; Cautious on GILD: Biotech stocks are on the rise again, but investors are bypassing Gilead because it has yet to produce a blockbuster follow-up for its hepatitis-C treatments. 
* Profile: Arvind Navaratnam of the Fidelity Event Driven Opportunities fund looks for corporate actions that will help him identify mispriced stocks (top 10 holdings: EXTN, MSG, FOX, BCO, ECPG, ADS, DEPO, TIME, FMCC, FNMA). 
* Small Caps: Positive on MPW: Shares of the REIT have taken a hit over concerns about operational and liquidity problems at ADPT, but the selloff appears overdone, and shares are now cheap. 
* Follow-Up: ANET is among smaller firms gaining ground on CSCO, and with a higher share price and greater operating momentum, investors should stick with it; Positive on VC: Shares could add another 20% as revenue and profits rise, and the company could be an acquisition target. 
* European Trader: Positive on Peugeot: French automaker's acquisition of Opel and Vauxhall from GM "is a relatively small deal financially, but strategically smart," as it will make Peugeot Europe's second-biggest car maker. 
* Asian Trader: "To sustain its gains, Hong Kong will need more capital flows from the mainland, because foreigners have not bought into China's recovery story yet. Actively managed funds are still selling." 
* Emerging Markets: Positive on Fomento Economico Mexicano: Mexican conglomerate has seen a rally recently, but shares still look undervalued given the diversity of the company's revenue streams. 
* Commodities: Analysts say sugar prices are likely to remain volatile in the months ahead, as uncertainties over weather conditions and production spark volatility. 
* CEO Spotlight: Profile of Airbus chief executive Thomas Enders, who wants to build on the company's presence in the Asia-Pacific region, North America, and Europe. 
* Streetwise: As the bull market enters its ninth year, investors should keep an eye on crude-and other commodity prices and be prepared for potential surprises.

>>> Iceland Central Bank (Sedabanki) announces new rules on foreign exchange tha

Iceland Central Bank (Sedabanki) announces new rules on foreign exchange that provide for liberalization of capital controls on households and business capital controls 
- Made changes to restrict undesirable inflows of foreign denominated capital that could create systemic risk through carry trade
- Capital controls on the country's individuals, firms and pension funds have been lifted with effect on Tuesday
- Central bank expects to acquire the majority of Krona help offshore, have acquired ~ISK90B from offshore holders of the currency
- Will buy offshore Krona using foreign exchange reserves, which currently are at an all time high

FT : Sanofi hails broader promise of eczema medicine

Sanofi hails broader promise of eczema medicine
Development comes after loss of patent protection on blockbuster drugs

Sanofi has hailed an eczema medicine tipped to be the biggest drug launch of the year as an “inflection point” as it tries to plug a revenue gap left by patent expiries on top-selling products.

If, as expected, US regulators approve Dupixent for treatment of the serious skin condition, analysts say the drug could generate peak annual sales of up to $6bn.

The development follows a difficult period for the French drugmaker that has lost patent protection on blockbuster medicines and twice failed to buy cutting-edge biotechnology companies, losing out in recent months to rivals Johnson & Johnson and Pfizer.

During late-stage clinical trials, about two-thirds of patients taking Dupixent with a steroid cream saw a dramatic improvement in their eczema, while nearly 40 per cent achieved clear or almost clear skin. Participants also reported a marked reduction in itching, the number one complaint among sufferers of atopic dermatitis.

The pathway targeted by Dupixent is also thought to have a role in several other conditions. Sanofi, in collaboration with Regeneron, a biotech that discovered the drug and will take half of the profits, is trialling the medicine in people with asthma, nasal polyps and food allergies, as well as children with atopic dermatitis.

Elias Zerhouni, president of global research and development at Sanofi, said the medicine marked “an inflection point . . . It is a pipeline in a single drug”.

The company has been under pressure to make up for the loss of patent protection two years ago on the last major drug in its portfolio. Lantus, the insulin medicine, had sales of more than $6bn in 2015. Analysts have estimated revenues generated by the drug will fall to about $2.9bn a year in 2020, emphasising the scale of the company’s challenge.

Dr Zerhouni said: “For Sanofi it’s really essential to overcome the patent cliff . . . We have to truly innovate with breakthrough drugs that can attack disease with two targets at once or three targets at once.”

Underlining the size of the potential market for Dupixent, he pointed out that more than 300m patients around the world suffered from asthma, “and it’s increasing in incidence”.

Adnan Butt, analyst at RBC Capital Markets, compared Dupixent with anti-inflammatory drugs such as AbbVie’s Humira and J&J’s Remicade. They were first approved for arthritis but went on to become top-selling medicines after being proven to work in a wide range of illnesses, generating a combined $23bn in sales last year.

“The revenue numbers could be very big based on the prevalence of severe-to-moderate atopic dermatitis in the wider population,” said Mr Butt.

Dr Zerhouni, who took the R&D helm after heading the National Institutes of Health in the US, said he had pushed the tie-up with Regeneron “in an effort to catch up in the field of biologics and to move [Sanofi] from being a traditional pharma company to a bio-pharma company. Because I just believed that science required that.”

His scientists were now focusing on other multi-targeted treatments, including one for diabetes, for which they were “developing molecules that have two and even three therapeutic actions at once. That is where the revolution is going to be,” he added.

FT : ECB could lift rates while tapering QE

ECB could lift rates while tapering QE
A warning on eurozone monetary policy sequencing and a clinical look at smart beta

Our round-up of the week’s best comment and analysis from the Financial Times focuses on the European Central Bank strategy, green investment and the future of India’s economy.

The selection is taken from our Markets Insight and Smart Money columns, written by industry contributors and FT commentators.

Olivier Garnier, a group chief economist at Société Générale, looks at the European Central Bank’s exit strategy from ultra-loose monetary policy. He warns investors not to rule out that the ECB could raise rates while it is still in the process of tapering its stimulus spending.

“Markets do not seem so far to have discounted the possibility of such a change in the sequencing of the ECB exit strategy. If circumstances were arguing in favour of this change, the central bank would thus have to prepare and communicate it well in advance.”

The Financial Times’ Stephen Foley describes positive and negative takes on the impact investing deal between the US hedge fund Mariner Investment and Crédit Agricole, which is a new twist on what is known as “synthetic securitisation”.

“The US hedge fund reckons it has found a way to turn an investment of about $150m into $2bn of new funding for renewable energy and other green projects.”

There are not enough data on the real-world impact that companies exert, such as greenhouse gas emissions, says Patrick Odier, senior managing partner in the Lombard Odier Group.

“This is one important reason why so-called ‘impact investing’ — which seeks out profitable ‘social enterprises’ whose goods explicitly make life more socially and environmentally sustainable — has tended to take the form of microfinance, private equity or debt, or Green Bonds.”

The FT’s John Authers describes an academic “clinical trial” of the five most popular Smart Beta factors: value, size, low-risk, momentum and income.

“In a pleasant surprise, the academics’ conclusion is upbeat. All five effects are genuine, in that they tend to cause stocks to perform differently (even if they do not always perform better) and all should be monitored by investors.”

Despite social support Narendra Modi, India’s prime minister, still needs to cut red tape, root out corruption and pick up investment to enhance the domestic stock market, the FT’s Henny Sender argues.

“Global optimism may be helping the stock market, but so far Mr Modi has largely been a disappointment for many investors. When Raghuram Rajan stepped down as governor of the Reserve Bank of India last June, the hope that the RBI would finally force banks to deal with their legacy of bad loans and unleash a new credit cycle in India vanished with him.”